MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this…
VideaHealth and Aspen Dental Launch One of Dentistry’s Largest AI Rollouts in Record Time, Redefining Patient Care Nationwide VideaHealth, the leading dental AI platform, and Aspen Dental Management, Inc., one of the nation’s largest and fastest-growing dental support organizations, today…
Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications Butterfly Network, Inc. a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP…
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with…
Innovate 32 Partners with Trivette Osborne & Associates, Expanding its Dental Services Presence in Tennessee Innovate 32 a rapidly expanding, partner-driven dental services organization, announced its partnership with Trivette Osborne & Associates, DDS, PLLC (“T&O”), a leading provider of comprehensive…
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune…
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been…
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition…
ZCG-Backed Unimed Acquires Regenboog Shipping Pharmacy Universal Maritime Solutions a leading global provider of medical and compliance solutions to the maritime industry, today announced the acquisition of Regenboog Shipping Pharmacy, a Netherlands-based distributor of pharmaceutical products and medical devices serving the…
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of…
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation…
Rapid Medical’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER™ 13 achieved superior…
